Sustained nitric oxide production in macrophages requires the arginine transporter CAT2

被引:187
作者
Nicholson, B
Manner, CK
Kleeman, J
MacLeod, CL
机构
[1] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
D O I
10.1074/jbc.M010030200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aberrant production of nitric oxide (NO) contributes to the pathogenesis of diseases as diverse as cancer and arthritis. Sustained NO production via the inducible enzyme, nitric-oxide synthase 2 (NOS2), requires extracellular arginine uptake. Three closely related cationic amino acid transporter genes (Cat1-3) encode the transporters that mediate most arginine uptake in mammalian cells. Because CAT2 is induced coordinately with NOS2 in numerous cell types, we investigated a possible role for CAT2-mediated arginine transport in regulating NO production. The complexity of arginine transport systems and their biochemically similar transport properties called for a genetic approach to determine the role of CAT2. CAT2-deficient mice were generated and found to be healthy and fertile in contrast to Cat1(-/-) animals. Analysis of cytokine-activated macrophages from Cat2(-/-) mice revealed a 92% reduction in NO production and a 95% reduction in L-Arg uptake. The reduction in NO production was not due to differences in NOS2 protein expression, NOS2 activity, or intracellular L-arginine content. In conclusion, our results show that sustained abundant NO synthesis by macrophages requires arginine transport via the CAT2 transporter.
引用
收藏
页码:15881 / 15885
页数:5
相关论文
共 35 条
  • [1] L-ARGININE TRANSPORT IS INCREASED IN MACROPHAGES GENERATING NITRIC-OXIDE
    BOGLE, RG
    BAYDOUN, AR
    PEARSON, JD
    MONCADA, S
    MANN, GE
    [J]. BIOCHEMICAL JOURNAL, 1992, 284 : 15 - 18
  • [2] Closs EI, 2000, MOL PHARMACOL, V57, P68
  • [3] CLOSS EI, 1993, J BIOL CHEM, V268, P7538
  • [4] Closs EI, 1996, AMINO ACIDS, V11, P193, DOI 10.1007/BF00813860
  • [5] Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice
    Detmers, PA
    Hernandez, M
    Mudgett, J
    Hassing, H
    Burton, C
    Mundt, S
    Chun, S
    Fletcher, D
    Card, DJ
    Lisnock, J
    Weikel, R
    Bergstrom, JD
    Shevell, DE
    Hermanowski-Vosatka, A
    Sparrow, CP
    Chao, YS
    Rader, DJ
    Wright, SD
    Puré, E
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (06) : 3430 - 3435
  • [6] Transporters for cationic amino acids in animal cells:: Discovery, structure, and function
    Devés, R
    Boyd, CAR
    [J]. PHYSIOLOGICAL REVIEWS, 1998, 78 (02) : 487 - 545
  • [7] A MAMMALIAN ARGININE LYSINE TRANSPORTER USES MULTIPLE PROMOTERS
    FINLEY, KD
    KAKUDA, DK
    BARRIEUX, A
    KLEEMAN, J
    HUYNH, PD
    MACLEOD, CL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) : 9378 - 9382
  • [8] FORTIER AH, 1994, CURRENT PROTOCOLS IM
  • [9] Interleukin-1 beta and tumor necrosis factor-alpha stimulate the cat-2 gene of the L-arginine transporter in cultured vascular smooth muscle cells
    Gill, DJ
    Low, BC
    Grigor, MR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) : 11280 - 11283
  • [10] HIBBS JB, 1987, J IMMUNOL, V138, P550